GRI GRI Bio, Inc.
$1.52▲ +2.70%
Healthcare
Other
Volume 6.6K
Avg Volume (10D) 48.0K
Key Metrics & Fundamentals
Market Cap
$3.32M
P/E Ratio
0.0
Div Yield
0.00%
52W Range
1.36 - 64.12
% vs 50 MA
-17.97%
% vs 200 MA
-35.70%
RSI-14
40.6
MACD Histogram
-0.0100
Beta (1Y vs SPY)
0.94
Free Cash Flow
-$1.45M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$1.65M
COGS
–
Operating Exp
$1.65M
Operating Income
-$1.65M
EBIT
-$1.65M
Pretax Income
-$1.64M
Net Income
-$1.64M
EPS (Diluted)
-0.91
Price & Volume History
Loading chart…
Recent News
GRI Bio to Highlight Immune Modulation and Phase 2a Development Insights in IPF at the 10th IPF Summit
GlobeNewswire · Sep 28, 2026 8:40 AM ET
GRI Bio, Inc. (GRI) Upgraded to Buy: What Does It Mean for the Stock?
Zacks · Sep 14, 2026 12:00 PM ET
GRI Bio Presents New Phase 2a Data at ERS 2026 Defining GRI-0621's Mechanism of Action in IPF Across Nine Mechanistic Pillars
GlobeNewswire · Sep 8, 2026 8:15 AM ET
GRI Bio Featured in "Why Now" On-Demand Video Webcast
GlobeNewswire · Aug 27, 2026 9:01 AM ET
GRI Bio to Present Late-Breaking Phase 2a GRI-0621 Data Highlighting Lung Function, Anti-Fibrotic Biomarkers and Favorable Tolerability in IPF at ERS 2026
GlobeNewswire · Aug 24, 2026 9:05 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See GRI's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.